Analyst Ratings for Eli Lilly (LLY) [Sells]
LLY Rating Summary
LLY Price Target Summary
- Highest: $1,250.00 (Citi)
- Lowest: $723.00 (Goldman Sachs)
- Average: $998.81
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$998.81 (+37.6%)
* Over Last 12-Mos
Rating Score: 7.7 / 10
Percentile Rank: 82%
Rating Score: 7.7 / 10
Percentile Rank: 82%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/15/2023 | Societe Generale | Florent Cespedes | Downgrade | Sell (Hold) |
278.00 (N/A) |
347.56 (725.72) |
108.8% | Details |
| 1/17/2013 | CLSA | N/A | New Coverage | Sell (5) (N/A) |
47.00 (N/A) |
52.93 (725.72) |
1271.09% | Details |
